1. Home
  2. DOV vs NTRA Comparison

DOV vs NTRA Comparison

Compare DOV & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dover Corporation

DOV

Dover Corporation

HOLD

Current Price

$206.56

Market Cap

27.7B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$242.89

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOV
NTRA
Founded
1947
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
DOV
NTRA
Price
$206.56
$242.89
Analyst Decision
Buy
Strong Buy
Analyst Count
10
15
Target Price
$220.20
$249.53
AVG Volume (30 Days)
1.0M
1.1M
Earning Date
01-29-2026
02-26-2026
Dividend Yield
1.01%
N/A
EPS Growth
45.52
N/A
EPS
16.27
N/A
Revenue
$7,923,358,000.00
$2,116,676,000.00
Revenue This Year
$5.31
$33.42
Revenue Next Year
$5.57
$16.96
P/E Ratio
$26.93
N/A
Revenue Growth
2.62
38.17
52 Week Low
$143.04
$125.38
52 Week High
$222.31
$256.36

Technical Indicators

Market Signals
Indicator
DOV
NTRA
Relative Strength Index (RSI) 60.09 57.64
Support Level $200.38 $226.66
Resistance Level $210.75 $250.00
Average True Range (ATR) 3.85 10.46
MACD 0.07 -0.12
Stochastic Oscillator 69.12 56.02

Price Performance

Historical Comparison
DOV
NTRA

About DOV Dover Corporation

Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: